UK medical cannabis registry: assessment of clinical outcomes in patients with headache disorders-Reference-Cited by-同舟云学术

UK medical cannabis registry: assessment of clinical outcomes in patients with headache disorders

Published:2023-01-02 Issue:1 Volume:23 Page:85-96
ISSN:1473-7175
Container-title:Expert Review of Neurotherapeutics
language:en
Short-container-title:Expert Review of Neurotherapeutics

Author:

Nicholas Martha¹,Erridge Simon¹²,Bapir Lara¹,Pillai Manaswini¹,Dalavaye Nishaanth¹,Holvey Carl²,Coomber Ross²³,Rucker James J²⁴⁵,Weatherall Mark W²⁶,Sodergren Mikael H¹²^ORCID

Affiliation:

1. Imperial College Medical Cannabis Research Group, Department of Surgery and Cancer, Imperial College London, London, UK

2. Department of Medicine, Sapphire Medical Clinics, London, UK

3. Department of Trauma and Orthopaedics, St. George’s Hospital NHS Trust, London, UK

4. Department of Psychological Medicine, Kings College London, London, UK

5. Centre for Affective Disorders, South London & Maudsley NHS Foundation Trust, London, UK

6. Department of Neurology, Buckinghamshire Healthcare NHS Trust, Amersham, UK

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Neurology (clinical),General Neuroscience

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737175.2023.2174017

Reference76 articles.

1. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010

2. Headache disorders: differentiating and managing the common subtypes

3. Migraine remains second among the world’s causes of disability, and first among young women: findings from GBD2019

4. Headaches

5. Sex Differences in the Prevalence, Symptoms, and Associated Features of Migraine, Probable Migraine and Other Severe Headache: Results of the American Migraine Prevalence and Prevention (AMPP) Study

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Psychotropic Drugs Reemerging as Headache Medicines;CNS Drugs;2024-07-22

2. Overview of global monitoring systems for the side effects and adverse events associated with medicinal cannabis use: a scoping review using a systematic approach;BMJ Open;2024-07

3. Marijuana;Reactions Weekly;2024-03-23

4. An overview of global monitoring systems for the side effects and adverse events associated with medicinal cannabis use: A scoping review using a systematic approach;2024-02-04

5. UK Medical Cannabis Registry: a case series analyzing clinical outcomes of medical cannabis therapy for generalized anxiety disorder patients;International Clinical Psychopharmacology;2024-02-02